Bioavailability of Different Formulas Enriched With DHA Using Wet Mixing or Dry Blending Method
NCT04460287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91
Last updated 2025-04-16
Summary
Infants and young children have high nutritional demands in order to support adequate growth and development, particularly during the transition from complementary feeding at 12 months of age to a mixed and varied diet at 36 months of age. Omega-3 long chain polyunsaturated fatty acid (n-3 LC-PUFA) such as docosahexaenoic acid (DHA; 22:6n-3) is the important constituents of the maturing brain, especially for visual and cognitive development. However only certain foods, such as fatty fish, contain n-3 LC-PUFA at concentrations sufficient for their needs. Additionally, these foods that are known to be rich in DHA may not be regularly provided to infants and toddlers due to concerns about potential food allergies or methylmercury exposure.
Although the importance of consuming n-3 LC-PUFA and essential fatty acids at the level of dietary recommendations in late infancy and early childhood (6-24 months) are highlighted, the current median n-3 LC-PUFA and estimated DHA intakes in toddlers in most countries are lower than the recommended levels. The European Food Safety Authority (EFSA) recommend that infants and young children (\< 24 months) should consume 100 mg of DHA per day, while for older children (2-18 years), they recommend a daily intake of 250 mg. In order to bridge the gap between the current intake and recommended levels of n-3 LC-PUFA, general foods, especially infant and toddler formulas, should be enriched with n-3 LC-PUFA particularly DHA. With a growing body of research, the challenge is to find an ideal formula that is nutritionally balanced and human milk-like, especially with respect to the ratio between omega-6 and omega-3 fatty acids and DHA level.
In adding DHA into the toddler formula, there are several methods, among others are in the form of wet mix and dry blending. The aim of this study is to compare the bioavailability of different methods of adding DHA (dry blend versus wet mix) into formulas in healthy Indonesian toddlers age 2-3 years old for a period of one month. Furthermore, to evaluate the stability of milk-based formulas that are supplemented with DHA under same storage conditions, so as to monitor the stability of infant formula.
Conditions
- Healthy Children
Interventions
- DIETARY_SUPPLEMENT
-
DHA Wet Mixing method
Children will drink milk contain 100 mg DHA wet mixing daily for 30 days
- DIETARY_SUPPLEMENT
-
DHA Dry Blending Method
Children will drink milk contain 100 mg DHA dry blending daily for 30 days
- DIETARY_SUPPLEMENT
-
Fish Oil
Children will have this intervention every day for 30 days
Sponsors & Collaborators
-
Indonesian Nutrition Association
lead OTHER
Principal Investigators
-
Diana Sunardi, Doctor · Faculty of Medicine University of Indonesia Cipto Mangunkusumo Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-02-17
- Primary Completion
- 2024-03-01
- Completion
- 2024-05-30
Countries
- Indonesia
Study Locations
More Related Trials
-
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds Follow-Up Study
NCT01112904 ·Status: COMPLETED
-
A Randomized Clinical Trial on Supplementation of DHA and AA to Preterm Infants
NCT00226187 ·Status: COMPLETED ·Phase: NA
-
Arachidonic Acid Supplementation in Very Preterm Infants
NCT02503020 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Docosahexaenoic and Eicosapentaenoic Acids in Hypercholesterolemic Children Plus Diet on Docosahexaenoic Acid (DHA) Status
NCT00678067 ·Status: COMPLETED ·Phase: NA
-
Cognitive and Mood Effects of Docosahexaenoic Acid (DHA)-Rich and Eicosapentaenoic Acid (EPA)-Rich Fish Oil in Healthy Young Adults
NCT01075919 ·Status: COMPLETED ·Phase: NA
-
Fish Oil Supplementation in Lactation
NCT00266305 ·Status: COMPLETED ·Phase: NA
-
Essential Fatty Acid Nutrition For 1-2 Yr-Olds
NCT01263912 ·Status: COMPLETED ·Phase: NA
-
Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function
NCT00662142 ·Status: COMPLETED ·Phase: PHASE3
-
Nutrigenomics, PUFA, Iron and Cognition Amongst Under-two-year-old Indonesian Children
NCT01504633 ·Status: UNKNOWN ·Phase: NA
-
Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo
NCT00342303 ·Status: COMPLETED
-
Bridging the Docosahexaenoic Acid (DHA) Gap: The Effects of Omega-3 Fatty Acid Supplementation in Premature Infants
NCT01908907 ·Status: COMPLETED ·Phase: NA
-
Omega-6/Omega-3 Ratio and Neural Development in Preterm Infants.
NCT02339727 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Essential Fatty Acids During Complementary Feeding
NCT00631046 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study on the Effect of DHA & ARA Candy on the Cognitive Improvement in Preschool Children
NCT06532435 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels
NCT03781557 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Docosahexaenoic Acid (DHA)-Enriched Human Milk in Premature Newborns
NCT01062373 ·Status: TERMINATED ·Phase: NA
-
Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2)
NCT03072277 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of DHA Supplementation on Cognitive Performance and Growth in Chinese Children
NCT02308930 ·Status: UNKNOWN ·Phase: NA
-
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds X Section
NCT01112930 ·Status: COMPLETED
-
Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age
NCT00351624 ·Status: COMPLETED ·Phase: PHASE3
-
Docosaexahenoic Acid and Gross Motor Milestones in Infants
NCT00610922 ·Status: COMPLETED ·Phase: NA
-
DHA & Lutein and fMRI Brain Mapping in Healthy Children
NCT01789866 ·Status: COMPLETED
-
The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities
NCT01875510 ·Status: COMPLETED ·Phase: NA
-
Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants
NCT02092857 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
NCT01007110 ·Status: COMPLETED ·Phase: PHASE3